Institutional Ownership Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE). We have compiled data on the 195 institutions that hold shares in the stock, with a total of 46.5 Million shares, which have been reported (via 13F filing form) to have a value of $341 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Wolff Wiese Magana LLC
|
Jan 14, 2025 Q4 2024 |
7
shares
|
$51
0.0% of portfolio
|
Q3 2023
Reduced 99.6%
|
|
|
Covestor LTD
Boston, MA |
Nov 01, 2024 Q3 2024 |
6
shares
|
$43
0.0% of portfolio
|
Q3 2024
Reduced 14.29%
|
|
|
Org Partners LLC
Roanoke, IN |
Jan 10, 2025 Q4 2024 |
5
shares
|
$36
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
First Horizon Advisors, Inc.
|
Nov 08, 2024 Q3 2024 |
1
shares
|
$7
0.0% of portfolio
|
Q2 2022
Reduced 93.33%
|
|
|
Activest Wealth Management
|
Jan 28, 2025 Q4 2024 |
1
shares
|
$7
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Huntington National Bank
Columbus, OH |
Nov 06, 2024 Q3 2024 |
1
shares
|
$7
0.0% of portfolio
|
Q2 2024
Reduced 98.97%
|
|
|
Nomura Asset Management CO LTD
Tokyo, M0 |
Nov 15, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q1 2023
New holding
|